Jeffrey Folick - Jun 24, 2021 Form 3 Insider Report for Bright Health Group Inc. (BHG)

Role
Director
Signature
/s/ Eric Halverson for Jeff Folick, Attorney-in-Fact
Stock symbol
BHG
Transactions as of
Jun 24, 2021
Transactions value $
$0
Form type
3
Date filed
6/24/2021, 09:57 PM
Previous filing
Jun 30, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BHG Common Stock 414K Jun 24, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BHG Series A Preferred Stock Jun 24, 2021 Common Stock 157K Direct F1
holding BHG Series B Preferred Stock Jun 24, 2021 Common Stock 30.9K Direct F2
holding BHG Series C Preferred Stock Jun 24, 2021 Common Stock 32.1K Direct F2
holding BHG Series D Preferred Stock Jun 24, 2021 Common Stock 13.3K Direct F2
holding BHG Stock Options (Right to Buy) Jun 24, 2021 Common Stock 125K $0.63 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 (1) Each share of the Issuer's Series A Preferred Stock will automatically convert into shares of the Issuer's common stock ("Common Stock") on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering and has no expiration date.
F2 Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, and Series D Preferred Stock will automatically convert into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering and has no expiration date.
F3 These stock options vest over four years as follows: (a) 25% vested on April 3, 2019 (one year after the grant date), and (b) 1/48 of the original grant amount (546,411) vests in monthly installments for the following three years.